IFN-γ release assays (IGRAs) (T-SPOT®.TB, based on Elispot, and QuantiFERON®, based on ELISA technology) show increased sensitivity and specificity when compared to the traditional tuberculin skin test (TST) [16]. This evidence concerns the gene IFNG and tuberculosis.